U.S. Coronavirus: Half of U.S. states report increased cases of Covid-19 and some leaders are taking new steps

“I’ve seen some things floating around about how we can’t enforce this because it’s an executive order,” the governor said. “They have the power of law [under] Kentucky law. ”

In New York, officials have noted several clusters of Covid-19 and the governor unveiled a new plan this week on how affected communities will move forward.

Cases are reported to be on the rise in 25 states

Kentucky and New York are among the 25 states that reported more new cases than last week.

Alaska and Montana registered record-high daily cases this week. In Ohio, the governor said the new cases are “upward-looking.”

More than 1,000 new cases were reported Monday in at least a dozen states. Four of them – California, North Carolina, Tennessee and Texas – had more than 2,000 infections.

In the U.S., cases are reported in only three states – Hawaii, Iowa and South Carolina.

“Instead of the autumn and winter going down sharply towards the lower baseline, we’re really going into the autumn and winter, ticketing some parts of the country, which eventually leads to not only more infections,” but more hospitalizations and then community outbreaks, which Will eventually develop and lead to mortality, ”Dr.

So far, more than 7.5 million infections have been reported – more than in any other country. More than 210,900 Americans have died, according to Johns Hopkins University.

Neurological symptoms in hospitalized patients

Meanwhile, as health officials track down the spread of the virus, many continue to research its effects on the body.

The study “highlights the high frequency and range of neurologic manifestations, occurring in more than four-quarters of hospitalized covid-19 patients in our hospital network system,” the researchers wrote in the study, published in the journal Annals Cl Clinical and Translational Neurology. On monday.

Researchers at the Northwestern University Feinberg School of Medicine found that at some point during their Covid-19 illness, 827% of patients had neurological symptoms such as headaches or encephalopathy, altered brain function or constitution.

The researchers also found that patients with any neurological symptoms were younger than outsiders.

“The fact that overall any neurologic manifestations are found in younger people is surprising, and may be explained by a greater clinical emphasis on the risk of respiratory failure than other symptoms in older patients,” the researchers wrote in their study. “In contrast, encephalopathy is more common in elderly patients.”

Updated guidelines for vaccines

U.S. The Food and Drug Administration also issued guidelines Tuesday for companies hoping to obtain Emergency Use Authorization (EUA) for the Covid-19 vaccine.

The FDA said companies must include at least a two-month follow-up after volunteers receive a second dose of the vaccine. That means no company will be able to find the EU before mid-November, as vaccines are at the forefront of clinical trials – made by Pfizer and Moderna – both requiring a 21- or 28-day wait between doses.

“It is important to be open and clear about the circumstances under which it is appropriate to authorize emergency use for the COVID-19 vaccine, to increase public confidence and to ensure the use of the COVID-19 vaccine once it is available,” said PV Marx. “, Which directs the FDA’s Center for Biological Evaluation and Research.

“I think comfortably around November or December, we will know if the vaccine is safe and effective,” he said.